Argen X Se Adr (ARGX)

Jan 15, 2025

argenx's SWOT analysis: biotech stock soars on VYVGART success, pipeline promise - Investing.com India

Jan 15, 2025

Jan 14, 2025

Argenx stock price target raised to $717 by H.C. Wainwright - Investing.com India

Jan 14, 2025

Jan 14, 2025

Are Medical Stocks Lagging Argenx (ARGX) This Year? - Yahoo Finance

Jan 14, 2025

Jan 13, 2025

Truist Securities raises argenx stock rating to Buy, says will exceed Vision 2030 - Investing.com

Jan 13, 2025

Jan 13, 2025

Jefferies raises argenx stock target, reaffirms buy on global sales result - Investing.com

Jan 13, 2025

Jan 07, 2025

argenx's SWOT analysis: biotech stock soars on vyvgart success - Investing.com

Jan 07, 2025

Jan 07, 2025

Piper Sandler increases argenx stock price target on revised estimates - Investing.com

Jan 07, 2025

Jan 06, 2025

Argenx stock soars to all-time high of $645.31 amid robust growth - Investing.com

Jan 06, 2025

Jan 06, 2025

argenx to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire Inc.

Jan 06, 2025

Dec 28, 2024

Argenx Secures Japanese Approval for VYVDURA in CIDP Treatment - Yahoo Finance

Dec 28, 2024

Dec 23, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Dec 23, 2024

Dec 16, 2024

Argenx stock soars to all-time high of $630.4 amid robust growth By Investing.com - Investing.com South Africa

Dec 16, 2024

Dec 16, 2024

Argenx stock soars to all-time high of $630.4 amid robust growth - Investing.com

Dec 16, 2024

Dec 15, 2024

argenx's SWOT analysis: biotech stock soars on VYVGART success - Investing.com

Dec 15, 2024

Dec 12, 2024

Upcoming Nasdaq-100 changes could boost the stocks of these 11 companies - MSN

Dec 12, 2024

Dec 09, 2024

Argenx Expands Autoimmune Portfolio With Additional Vyvgart Approvals as Pipeline Develops - Morningstar

Dec 09, 2024

Dec 09, 2024

Piper Sandler maintains stock target on argenx, cites growth potential - Investing.com

Dec 09, 2024

Dec 02, 2024

Argenx stock soars to all-time high of $620.29 - Investing.com

Dec 02, 2024

Nov 30, 2024

10 High Growth Healthcare Stocks to Invest in Now - Insider Monkey

Nov 30, 2024

Nov 26, 2024

Argenx stock soars to all-time high of $612.64 amid robust growth By Investing.com - Investing.com South Africa

Nov 26, 2024

Nov 26, 2024

Argenx stock soars to all-time high of $612.64 amid robust growth - Investing.com India

Nov 26, 2024

Nov 25, 2024

argenx's SWOT analysis: biotech firm's stock soars on VYVGART success - Investing.com

Nov 25, 2024

Nov 25, 2024

Jefferies reaffirms Buy rating on argenx stock, ups target amid promising trial updates - Investing.com India

Nov 25, 2024

Nov 21, 2024

Can Argenx stock sustain its autoimmune category dominance? Oppenheimer weighs in - Investing.com

Nov 21, 2024

Nov 21, 2024

Barclays bullish on argenx stock after positive trial results - Investing.com

Nov 21, 2024

Nov 21, 2024

Barclays bullish on argenx stock after positive trial results By Investing.com - Investing.com South Africa

Nov 21, 2024

Nov 20, 2024

argenx shares see price target boosted by Raymond James, Strong Buy rating upheld - Investing.com

Nov 20, 2024

Nov 18, 2024

10 Biggest Biotechnology Companies - Investopedia

Nov 18, 2024

Nov 12, 2024

Argenx upgraded at Wolfe on myasthenia gravis dominance - MSN

Nov 12, 2024

Nov 12, 2024

argenx stock boosted by Wolfe, citing dominance in MG and profitability ahead - Investing.com

Nov 12, 2024

Nov 11, 2024

Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China - Yahoo Finance

Nov 11, 2024

Nov 05, 2024

Scotiabank raises argenx stock PT to $715, highlights efgartigimod's potential - Investing.com India

Nov 05, 2024

Nov 05, 2024

argenx SE's SWOT analysis: biotech stock poised for growth amid challenges - Investing.com

Nov 05, 2024

Nov 04, 2024

Deutsche Bank raises argenx target by EUR25, acknowledges momentum despite valuation - Investing.com

Nov 04, 2024

Nov 01, 2024

Argenx shares target raised by H.C. Wainwright, citing strong sales performance - Investing.com

Nov 01, 2024

Nov 01, 2024

Argenx Q3 Revenue, EPS Beats Excite Bullish Biotech Analysts: 'Most Enviable I&I Pipeline In Entire Industry' - Benzinga

Nov 01, 2024

Nov 01, 2024

Argenx shares target lifted, overweight on Vyvgart sales beat - Investing.com

Nov 01, 2024

Nov 01, 2024

argenx stock downgraded after 65% rally, Baird cites limited short-term upside - Investing.com India

Nov 01, 2024

Nov 01, 2024

William Blair bullish on argenx stock as Vyvgart flexes in CIDP and eyes new horizons - Investing.com India

Nov 01, 2024

Nov 01, 2024

Raymond James maintains outperform on argenx, cites strong sales - Investing.com India

Nov 01, 2024

Nov 01, 2024

argenx stock climbs as Truist highlights industry-leading I&I pipeline growth - Investing.com India

Nov 01, 2024

Nov 01, 2024

Stifel sees upside in argenx stock with robust pipeline and solid 3Q results - Investing.com

Nov 01, 2024

Oct 31, 2024

Earnings call: argenx sees growth with VYVGART, sets sights on CIDP - Investing.com Nigeria

Oct 31, 2024

Oct 31, 2024

Earnings call: argenx sees growth with VYVGART, sets sights on CIDP By Investing.com - Investing.com South Africa

Oct 31, 2024